Abstract nr
Supportive Care and Palliation
Proffered Paper Session: Supportive Care and Palliation
Chair: A. Charalambous (Cyprus)
Chair: Y. van der Linden (Netherlands)
09:00
1500
Long term toxicities after cisplatin-based concurrent chemoradiation in head & neck squamous cell carcinoma (HNSCC) disease-free patients: A cross-sectional study
Speaker: T. Giollo Rivelli (Brazil)
09:15
1501
Safety and efficacy of biosimilar filgrastim in patients with lung cancer undergoing neutropenia-inducing chemotherapy: A sub-analysis of the NEXT study
Speaker: D. Kamioner (France)
09:30
1502
Visualization and relaxation as anxiety reducing techniques in breast and prostate cancer patients undergoing chemotherapy: Findings from a randomized controlled trial
Speaker: A. Charalambous (Cyprus)
09:45
Discussant : F. Strasser (Switzerland)
09:55
1503
Impact of pain on survival in metastatic cancer patients treated with chemotherapy: A prospective longitudinal study of patient-reported severity
Speaker: R.T. Elaidi (France)
10:10
1504
Impact of worsening in patient reported symptomatic adverse events (AEs) on deterioration of daily assessed quality of life (QOL) in cancer patients receiving initial chemotherapy; prospective exploratory study
Speaker: Y. Horie (Japan)
10:25
1505
Chemotherapy-induced pain and neuropathy: A prospective study in patients treated with adjuvant oxaliplatin or docetaxel
Speaker: L. Ventzel (Denmark)
10:40
Discussant : N.I. Cherny (Israel)
10:50
34LBA
LATE BREAKING ABSTRACT: Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: A multinational randomised, placebo-controlled, double-blind trial – the GAND-emesis study
Speaker: C.H. Ruhlmann (Denmark)
11:00
35LBA
LATE BREAKING ABSTRACT: Supersaturated calcium-phosphate rinse reduces dry mouth and burning sensation in cancer patients treated with TKI and mTORi – Results of a double-blind, randomised phase III trial (NCT01265810)
Speaker: C. Boers-Doets (Netherlands)
11:10
Discussant : S. Kaasa (Norway)